Articles

Friday Pearls

Friday Pearls

Curcumin: A Spice for All Seasons

Friday, October 28, 2005

Curcumin is a dietary compound with diverse antioxidant, anti-inflammatory and anti-carcinogenic effects. The strong anti-oxidative activity in curcuminoids, the main yellow pigments in Curcuma longa (turmeric), have been used widely and for a long time in the treatment of chronic inflammation in indigenous medicine.

Biosyntrx Launches Two New Products at AAO

Friday, October 21, 2005

The American Academy of Ophthalmology annual meeting proved to be a great launching pad for two new Biosyntrx products: Zeaxanthin4 and ZoOmega-3. Peer-reviewed science strongly supports the use of high-quality concentrated supplemental Omega-3s on days that cold water fish is not consumed, and zeaxanthin science continues to strongly suggest that the central macula preference is for zeaxanthin, not lutein.

Ginkgo biloba: Friend or Foe

Friday, October 07, 2005

At first glance, a National Library of Medicine search shows literature suggesting increased bleeding time with Ginkgo biloba. This is of extreme concern to many, including macula degeneration patients. However, almost all titles listed are anecdotal letters to journals, not evidence-based science. The well-meaning letters almost never address the amount of Ginkgo the bleeding patient was taking, nor do most of the published letters include a list of the other prescription and OTC medications the patient with a bleed was ingesting.

The Allergic Dry Eye and Inflammation

Friday, September 30, 2005

Ocular allergy can be broadly classified into four disease subcategories: seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis (PAC), vernal keratoconjunctivitis (VKC), and atopic keratoconjunctivitis (AKC). It is estimated that over 20% of the general population suffers from some form of ocular allergy. Of those, over 90% have SAC, PAC, or both.

AMD Awareness Internet Conference

Friday, September 16, 2005

In keeping with their commitment to provide up-to-date and useful information to macular degeneration patients and their families, the non-profit foundations that make up the International AMD Alliance are sponsoring the first AMD Awareness Internet Conference during AMD Awareness Month 2005. The conference dates are Sept 22nd -24th.

Serum Lycopene Decreases in AMD Patients

Friday, September 09, 2005

Age Related Macula Degeneration seems to result from cumulative oxidative damages suggesting that antioxidants can exert a protective effect against this pathology. A recently published peer-reviewed study suggests that serum levels of the carotenoid lycopene decrease in AMD patients, while serum levels of lutein and zeaxanthin do not. This study suggests that it takes a village of carotenoids to properly protect the macula.

Betty Kamen, PhD: A Living Legend

Friday, September 02, 2005

It is most appropriate for the Biosyntrx research team to use the Labor Day weekend Friday Pearl to honor Dr. Betty Kamen, a member of our Scientific Advisory Board, for her half century of labor and outstanding contributions to the field of nutrition education. Betty recently celebrated her 80th birthday. She is living proof that insatiable curiosity (academic and otherwise), good nutrition, commitment to family, fitness, and the work you love, can be the key to looking beautifully radiant and feeling good at every age.

Where Are The Bodies?

Friday, August 26, 2005

Dietary supplements have an extraordinarily safe usage history. In the United States, close to half of the population takes herbal or nutritional supplements every day. Andrew Saul, PhD, nutritionist and former health science and biology professor at State University of New York (SUNY) suggests that this amounts to over 145,000,000 individual daily doses, for a total of just under 53 billion doses annually. The most elementary of forensic arguments to the much publicized CODEX-FDA call for tighter controls on the supplement industry is - where are the bodies?

Smoking: A Call to Action

Friday, August 12, 2005

The untimely death of Peter Jennings from cigarette smoking related lung cancer suggests the need to discuss the increased risk factor for several eye diseases in those who smoke; including macular degeneration, glaucoma, cataract, diabetic retinopathy, optic neuropathy and neuritis, and dry eyes. Cigarette smoking is the single biggest preventable cause of death and disability in developed countries and it is one of our most significant public health concerns. The literature strongly suggests that ischemic, toxic, and oxidative effect of cigarette smoking plays an important role in damaging all ocular tissue.

The AMD Inflammation Debate Continues

Thursday, July 28, 2005

Conflicting Age-Related Macula Degeneration studies published in the past 60 days by reputable journals add fuel to the AMD inflammation fires. Recent studies published in Archives of Ophthalmology and The American Journal of Ophthalmology support differing points of view.

Pages:  1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27  |  28  |  29  |  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  |  41  |  42  |  43  |  44  |  45  |  46  |  47  |  48